IDEAS home Printed from https://ideas.repec.org/a/inm/orinte/v28y1998i3p23-33.html
   My bibliography  Save this article

Can Difficult-to-Reuse Syringes Reduce the Spread of HIV Among Injection Drug Users?

Author

Listed:
  • Jonathan P. Caulkins

    (Carnegie Mellon University, Heinz School, Pittsburgh, Pennsylvania 15213-3890)

  • Edward H. Kaplan

    (Yale School of Management, New Haven, Connecticut 06520-8200)

  • Peter Lurie

    (Center for AIDS Prevention Studies, University of California, San Francisco, California 94105)

  • Thomas O'Connor

    (5612 Maryland, #2, Chicago, Illinois 60637)

  • Sung-Ho Ahn

    (RAND, PO Box 2138, Santa Monica, California 90407-2138)

Abstract

Sharing of syringes by injection drug users is a principal means by which the human immunodeficiency virus (HIV) is spread. Some have suggested that distributing syringes that are difficult to reuse (DTR) would slow the spread of HIV. We developed a simple mathematical model that describes how changes in the numbers of DTR syringes or regular syringes consumed over the course of a fixed number of injections affects the proportion of injections that are potentially infectious and, thus, the transmission of HIV. It suggests that increasing consumption of either type of syringe will reduce the proportion of potentially infectious injections, but that, per syringe added, the reduction is always greater if a regular rather than a DTR syringe is added. Similarly, introducing a certain number of DTR syringes and simultaneously reducing the consumption of regular syringes by the same number will increase, not decrease, the proportion of infectious injections. DTR syringes are more expensive than regular syringes, so there is little justification for substituting them for regular syringes.

Suggested Citation

  • Jonathan P. Caulkins & Edward H. Kaplan & Peter Lurie & Thomas O'Connor & Sung-Ho Ahn, 1998. "Can Difficult-to-Reuse Syringes Reduce the Spread of HIV Among Injection Drug Users?," Interfaces, INFORMS, vol. 28(3), pages 23-33, June.
    • Handle: RePEc:inm:orinte:v:28:y:1998:i:3:p:23-33
    DOI: 10.1287/inte.28.3.23
    as

    Download full text from publisher

    File URL: http://dx.doi.org/10.1287/inte.28.3.23
    Download Restriction: no
    File URL: https://libkey.io/10.1287/inte.28.3.23?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Holmberg, S.D., 1996. "The estimated prevalence and incidence of HIV in 96 large US metropolitan areas," American Journal of Public Health, American Public Health Association, vol. 86(5), pages 642-654.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Iguchi, Martin Y. & Bux, Donald A. & Kushner, Harvey & Lidz, Victor, 2001. "Correlates of HIV risk among female sex partners of injecting drug users in a high-seroprevalence area," Evaluation and Program Planning, Elsevier, vol. 24(2), pages 175-185, May.
    2. Barton H. Hamilton & Andrés Hincapié & Robert A. Miller & Nicholas W. Papageorge, 2021. "Innovation And Diffusion Of Medical Treatment," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 62(3), pages 953-1009, August.
    3. Georgiy Bobashev & Sarah Mars & Nicholas Murphy & Clinton Dreisbach & William Zule & Daniel Ciccarone, 2019. "Heroin type, injecting behavior, and HIV transmission. A simulation model of HIV incidence and prevalence," PLOS ONE, Public Library of Science, vol. 14(12), pages 1-17, December.
    4. Lessner, Lawrence, 2008. "HIV prevalence for New York State using Newborn Seroprevalence and AIDS Surveillance Data," Socio-Economic Planning Sciences, Elsevier, vol. 42(4), pages 286-299, December.
    5. Steven D. Pinkerton & David R. Holtgrave & Laura C. Leviton & David A. Wagstaff & Paul R. Abramson, 1998. "Model-Based Evaluation of Hiv Prevention Interventions," Evaluation Review, , vol. 22(2), pages 155-174, April.
    6. Ana P. Johnson-Masotti & Purushottam W. Laud & Raymond G. Hoffmann & Matthew J. Hayat & Steven D. Pinkerton, 2001. "Probabilistic Cost-Effectiveness Analysis of HIV Prevention," Evaluation Review, , vol. 25(4), pages 474-502, August.
    7. A. David Paltiel & Harold A. Pollack, 2010. "Price, Performance, and the FDA Approval Process: The Example of Home HIV Testing," Medical Decision Making, , vol. 30(2), pages 217-223, March.
    8. Amy Lansky & Teresa Finlayson & Christopher Johnson & Deborah Holtzman & Cyprian Wejnert & Andrew Mitsch & Deborah Gust & Robert Chen & Yuko Mizuno & Nicole Crepaz, 2014. "Estimating the Number of Persons Who Inject Drugs in the United States by Meta-Analysis to Calculate National Rates of HIV and Hepatitis C Virus Infections," PLOS ONE, Public Library of Science, vol. 9(5), pages 1-9, May.
    9. Schilling, Robert F. & Fernando, Daniel & Fontdevila, Jorge & El-Bassel, Nabila, 2000. "HIV risk reduction among injection drug users: explaining the lack of anticipated outcomes in a community-level controlled comparison study," Evaluation and Program Planning, Elsevier, vol. 23(3), pages 301-313, August.
    10. Wilson, Amy R. & Kahn, James G., 2003. "Preventing HIV in injection drug users: exploring the tradeoffs between interventions," Socio-Economic Planning Sciences, Elsevier, vol. 37(4), pages 269-288, December.
    11. Schilling, Robert F. & Fontdevila, Jorge & Fernando, Daniel & El-Bassel, Nabila & Monterroso, Edgar, 2004. "Proximity to needle exchange programs and HIV-related risk behavior among injection drug users in Harlem," Evaluation and Program Planning, Elsevier, vol. 27(1), pages 25-33, February.
    12. Wilson, Amy R. & Kahn, James G. & Oren, Shmuel S., 2005. "Targeting interventions to high-risk populations: Benefits and costs," Socio-Economic Planning Sciences, Elsevier, vol. 39(4), pages 335-349, December.
    13. Steven D. Pinkerton & Eric G. Benotsch & John Mikytuck, 2007. "When Do Simpler Sexual Behavior Data Collection Techniques Suffice?," Evaluation Review, , vol. 31(4), pages 401-412, August.
    14. Ana P. Johnson-Masotti & Purushottam W. Laud & Raymond G. Hoffmann & Matthew J. Hayat & Steven D. Pinkerton, 2004. "A Bayesian Approach to Net Health Benefits: An Illustration and Application to Modeling HIV Prevention," Medical Decision Making, , vol. 24(6), pages 634-653, November.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:inm:orinte:v:28:y:1998:i:3:p:23-33. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Asher (email available below). General contact details of provider: https://edirc.repec.org/data/inforea.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.